Navigation Links
The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
Date:1/7/2009

WHITE PLAINS, N.Y. and KANSAS CITY, Kan., Jan. 7 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and The University of Kansas Cancer Center have announced a partnership to translate discoveries by LLS-funded researchers into Phase I clinical trials.

Currently, The University of Kansas Cancer Center (KU Cancer Center) and its partner, Beckloff Associates Inc., are supporting two early stage projects of LLS-funded researchers at The University of Virginia and The University of Toronto. The number of projects is expected to expand over the year.

The University of Kansas is uniquely positioned to work with LLS to accelerate the research it funds. KU Cancer Center has a long history of developing cancer drugs and currently has the No. 1 pharmacy school, in terms of National Institutes of Health (NIH) funding. KU Cancer Center holds a development contract with the National Cancer Institute (NCI) and has helped formulate seven out of the 19 drugs developed through NCI's Developmental Therapeutics Program.

Integral to moving projects rapidly into clinical trials is KU Cancer Center's partnership with industry. Beckloff Associates Inc., based in Overland Park, KS, provides development and regulatory support on the projects. Through these collaborative efforts and the formation of multi-disciplinary, multi-organizational, high-performance project teams, drug projects are advanced rapidly.

The partnership between KU Cancer Center and LLS is part of LLS's Therapy Acceleration Program, which supports private sector and academic-based projects with the goal of moving blood cancer therapies into the development pipeline. KU Cancer Center is the first academic partner in the program.

"By leveraging the capabilities and strengths The University of Kansas has in place, this partnership brings
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Grape Seed Extract Kills Leukemia Cells in Lab
2. Stem cells and leukemia battle for marrow microenvironment
3. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
4. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
5. Dismissed leukemia drug helps cll patients, studies show
6. Novel treatments show improvements in survival and response rates for leukemia and lymphoma
7. Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma
8. 50 years of hairy-cell leukemia research to be observed
9. Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
10. Adult survivors of childhood leukemia have lower bone mineral density, study finds
11. UCSD researchers identify potential new drug target for chronic leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...HINGTON, Nov. 9 The Churchill Ce...ward For Leadership to J.W. "Bill" Marriott for hi...gh progressive free market practices and fostering...Mr. Marriott will receive his award at a ceremony ...on D.C. Four Seasons Hotel. ,, "This is a test...
(Date:11/9/2009)... ANGELES, Nov. 9 Tracy Anderson, t...nd Kate Hudson, will be hosting two events at her ...Finally sharing her long awaited Nutritional Meal ...ng her TA Baby Food Cleanse and Lifestyle Menu. S...porates her entire method of cardio and muscle str...
(Date:11/9/2009)...y be left atrial enlargement, study finds , ...s a major risk factor for left atrial enlargement,...stroke and death, a new study shows. , Atrial f...(an irregular heart rhythm or heartbeat). , Re...ed 25 to 74, in Germany who were followed for 10 y...
(Date:11/9/2009)... Studying Genetic Variance Across ... of Genes , (Vocus) Novem...tries can be extraordinarily valuable when analyzi...-center genetics study that scanned the genomes ...regional differences, Drs. Chao Tian and Michael F...
(Date:11/9/2009)...ly due to fact that both eye conditions are age-re...9 (HealthDay News) -- Cataract surgery doesn,t app...r degeneration (AMD), according to a new study tha... vision loss worsens the other. , "Because both...uals with cataract also have AMD," wrote Li Ming D...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 2Health News:News from the November/December Issue of Molecular Medicine 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2
...eam of doctors from different specialties, recentl...roach can benefit cancer patients. Dr. Peter Costa... found a rare and often fatal tumor in Angela Carr...gnosed in 2002. This type of cancer makes up about...
...ry year, more than 5 million people go to the Emer... for 20 to 30 minutes. Most receive an ECG and oth...a heart attack or other serious heart problems. Ho...in. Researchers suggest// that about 2 percent of ...
...riasis patients who have been long-awaiting new op...ood and Drug Administration's approval of the new ...immune cells to control hard-to-treat psoriasis. P...that are currently available for psoriasis range f...
...ple have been concerned, for many decades now, abo...e smile. But tooth discolouration is a persistent ...les in food and drink. Back in the Middle Ages, pe...red many easy and ingenuous ways of maintaining te...
...ecent study has has shown that oxygen, apart from ... Prior studies have shown that oxygen plays an imp.... In fact, studies have shown treatment in a hyper...ity. The researchers of the new have now suggested...
...nking milk has always been associated with good he...o drink milk to grow up healthy. However, a recent... well established fact(or is it still?). A study i...ein and the national rate of heart disease and ins...
Other Medicine News:Health News:New and unique treatment for Psoriasis patients 2
(Date:11/9/2009)..., AUSTIN, Texas, Nov. 9 Celli...rs, is collaborating with Tissue Genesis, Inc. to ... derived adult stem cells. SpineSmith acquired th...se (fat) tissue derived stem cell technology in No...this new exclusive agreement allows Celling Techno...
(Date:11/9/2009)..., ST. LOUIS, Nov. 9, 2009 /PRNewswire-FirstCa...nc (NYSE: PFE ) today announced that they have en...izer,s Chesterfield Village Research Center locate...eement, Monsanto will acquire the property from Pf...izer will continue to have operations at Chesterfi...
(Date:11/9/2009)..., PISCATAWAY, N.J., Nov. 9 /PRNewswire-FirstC...ard: MLSS), the recognized leader in computer-cont...t it will be showcasing its patented, award-winnin...ystem) at the Madow Group,s 15th year of TBSE tit... place at the Las Vegas Hilton. ,, The STA S...
Breaking Medicine Technology:Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 1Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 2Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 3Video of EpiDerm Skin Irritation Test 28SIT 29 Method Now Available 13170 1Video of EpiDerm Skin Irritation Test 28SIT 29 Method Now Available 13170 2Twinlabs 28R 29 Mobile Beach Bash Heats Up After a Successful Kick Off of the 2009 RateYourAbs com Contest 52549 1Twinlabs 28R 29 Mobile Beach Bash Heats Up After a Successful Kick Off of the 2009 RateYourAbs com Contest 52549 2
....Y.--(BUSINESS WIRE)--Jun 18, 2007 - Advanced Vira...iopharmaceutical,company, announced today that pre...ological study show topical treatment with AVR118,...ammation and,redness associated with surgical inci...open label dermatological study is evaluating the,...
...an 70 abstracts highlight VELCADE efficacy in broa...-, CAMBRIDGE, Mass., June 19, 2007 /PRNewswire-Fir...announced that data for,VELCADE, the market leadin...or patients with previously treated multiple myelo...ional Myeloma,Workshop (IMW) in Kos, Greece, June ...
Other Medicine Technology:Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8
DeepLight Glaucoma Treatment System
Verity Adx Pacemaker
Regency Pacemaker
Identity® Adx Pacemaker
Medicine Products: